Section 1 Short title
This Act may be cited as the “NAPA Reauthorization Act”.
NAPA Reauthorization Act
AN ACT
To extend the National Alzheimer's Project.
Sec. 2 Extension of project
Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225) is amended—
in subsection (c)—
in paragraph (2), by striking “and coordination of” and inserting “on, and coordination of,”;
in paragraph (4)—
by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and
by inserting before subparagraph (B), as so redesignated, the following:
“(A) promotion of healthy aging and reduction and mitigation of risk factors for Alzheimer's;”
in paragraph (5)—
by inserting “and other underserved populations, including individuals with developmental disabilities such as Down syndrome,” after “populations”; and
by striking “; and” and inserting a semicolon;
by redesignating paragraph (6) as paragraph (7); and
by inserting after paragraph (5) the following:
“(6) provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and”
in subsection (d)(2)—
by inserting “, across public and private sectors,” after “Nation's progress”; and
by inserting “, including consideration of public-private collaborations, as appropriate” before the period;
in subsection (e)—
in paragraph (2)—
in subparagraph (A), by adding at the end the following:
“(xi) A designee of the Department of Justice.
“(xii) A designee of the Federal Emergency Management Agency.
“(xiii) A designee of the Social Security Administration.
“(xiv) 2 or more other designees, as determined by the Secretary of Health and Human Services, at least one of whom has expertise in risk factors associated with the development or the progression of Alzheimer's.”
in subparagraph (B)—
in the matter preceding clause (i), by striking “12” and inserting “15”;
in clause (v)—
by striking “2 researchers” and inserting “3 researchers”; and
by striking “; and” and inserting “, including at least one researcher with demonstrated experience in recruitment and retention of underrepresented groups into research or clinical trials related to dementia;”;
in clause (vi), by striking the period and inserting a semicolon; and
by adding at the end the following:
“(vii) 1 individual with a diagnosis of Alzheimer's disease; and
“(viii) 1 representative from a historically underserved population whose lifetime risk for developing Alzheimer's is markedly higher than that of other populations.”
in paragraph (5)—
in subparagraph (A)—
by striking “an initial evaluation” and inserting “annual evaluations”; and
by striking “research, clinical” and inserting “research, risk reduction, public health, clinical”;
in subparagraph (B), by striking “initial”;
in subparagraph (C)—
in the matter preceding clause (i), by striking “initial”; and
in clause (ii), by inserting “and reduce disparities” before the semicolon; and
in subparagraph (D), by striking “annually thereafter, an evaluation” and inserting “annual evaluations”; and
in paragraph (6), by striking “2025” and inserting “2035”;
in subsection (g)—
in paragraph (1)—
by adding “and” after the semicolon;
by striking “that includes an evaluation” and inserting “that includes—
“(A) an evaluation;”
by adding at the end the following:
“(B) a summary of the Secretary's process for identifying and updating what conditions constitute Alzheimer's disease;”
in paragraph (3)(A)(ii), by inserting “and reduce disparities” before the semicolon; and
in subsection (h), by striking “2025” and inserting “2035”.